Literature DB >> 9525971

Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.

T Saito1, T Endo, A Kawaguchi, M Ikeda, R Katoh, A Kawaoi, A Muramatsu, T Onaya.   

Abstract

Iodide is concentrated to a much lesser extent by papillary thyroid carcinoma as compared with the normal gland. The Na+/I- symporter (NIS) is primarily responsible for the uptake of iodide into thyroid cells. Our objective was to compare NIS mRNA and protein expression in papillary carcinomas with those in specimens with normal thyroid. Northern blot analysis revealed a 2.8-fold increase in the level of NIS mRNA in specimens with papillary carcinoma versus specimens with normal thyroid. Immunoblot analysis using anti-human NIS antibody that was produced with a glutathione S-transferase fusion protein containing NIS protein (amino acids 466-522) showed the NIS protein at 77 kD. The NIS protein level was elevated in 7 of 17 cases of papillary carcinoma but was not elevated in the normal thyroid. Immunohistochemical staining revealed abundant NIS in 8 of 12 carcinomas, whereas NIS protein was barely detected in specimens with normal thyroid. Although considerable patient-to-patient variation was observed, our results indicate that NIS mRNA is elevated, and its protein tends to be more abundant, in a subset of papillary thyroid carcinomas than in normal thyroid tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525971      PMCID: PMC508706          DOI: 10.1172/JCI1259

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.

Authors:  T Saito; T Endo; A Kawaguchi; M Ikeda; M Nakazato; T Kogai; T Onaya
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

2.  Presence of TSH receptor in thyroid neoplasms.

Authors:  Y Ichikawa; E Saito; Y Abe; M Homma; T Muraki
Journal:  J Clin Endocrinol Metab       Date:  1976-02       Impact factor: 5.958

3.  The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma.

Authors:  R D Leeper
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

4.  Treatment of thyroid cancer. Death rates after surgery and after surgery followed by sodium iodide I-131.

Authors:  V M Varma; W H Beierwaltes; M M Nofal; R H Nishiyama; J E Copp
Journal:  JAMA       Date:  1970-11-23       Impact factor: 56.272

5.  Changing end results in patients with papillary carcinoma of the thyroid.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1971-03

6.  T.S.H. receptor and adenylate cyclase in undifferentiated thyroid carcinoma.

Authors:  Y Abe; Y Ichikawa; M Homma; K Ito; T Mimura
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

7.  Prospects from the treatment of thyroid carcinoma with radioiodine.

Authors:  E E Pochin
Journal:  Clin Radiol       Date:  1967-04       Impact factor: 2.350

8.  Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine.

Authors:  C J Edmonds; S Hayes; J C Kermode; B D Thompson
Journal:  Br J Radiol       Date:  1977-11       Impact factor: 3.039

9.  Influence of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for thyroid cancer.

Authors:  J M Goldman; B R Line; R L Aamodt; J Robbins
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

10.  Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity.

Authors:  P Carayon; C Thomas-Morvan; E Castanas; M Tubiana
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

View more
  22 in total

Review 1.  Regulation of sodium/iodide symporter.

Authors:  S M Jhiang
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  A Nonpump Function of Sodium Iodide Symporter in Thyroid Cancer via Cross-talk with PTEN Signaling.

Authors:  Fang Feng; Lamis Yehia; Ying Ni; Yi Seok Chang; Sissy Meihua Jhiang; Charis Eng
Journal:  Cancer Res       Date:  2018-09-14       Impact factor: 12.701

Review 3.  The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Authors:  Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard Vile; Kevin Harrington
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

4.  Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.

Authors:  E H Kemp; E A Waterman; R A Ajjan; K A Smith; P F Watson; M E Ludgate; A P Weetman
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

5.  Expression of sodium iodide symporter in benign and malignant human thyroid tissues.

Authors:  J D Lin; C Hsueh; T C Chao; H F Weng
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 6.  Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.

Authors:  Stefania Bulotta; Marilena Celano; Giuseppe Costante; Diego Russo
Journal:  Endocrine       Date:  2015-12-21       Impact factor: 3.633

7.  Differential expression of the Na(+)/I(-) symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues.

Authors:  Shasha Wang; Jun Liang; Yansong Lin; Ruyong Yao
Journal:  Oncol Lett       Date:  2012-10-01       Impact factor: 2.967

8.  A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.

Authors:  Vicki E Smith; Martin L Read; Andrew S Turnell; Rachel J Watkins; John C Watkinson; Greg D Lewy; Jim C W Fong; Sally R James; Margaret C Eggo; Kristien Boelaert; Jayne A Franklyn; Christopher J McCabe
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

9.  Association between sodium iodide symporter and differentiated Thyroid cancer: a meta-analysis of 9 studies.

Authors:  Rui Zhang; Huanjun Wang; Junyu Zhao; Jinming Yao; Hongxia Shang; Huangao Zhu; Lin Liao; Jianjun Dong
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 10.  Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy.

Authors:  Patrick Baril; Pilar Martin-Duque; Georges Vassaux
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.